Atlas Trials

Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma

Clinical trial NCT00354107 · TERMINATED

Trial details

NCT number
NCT00354107
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Anaplastic Large Cell LymphomaRecurrent Childhood Anaplastic Large Cell Lymphoma
Start date
2007-01-01
Primary completion
2010-01-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.